Hideki Muramatsu

Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

Toyoaki Hida, Yasushi Yatabe, Hiroyuki Achiwa et al. · PubMed · 1998 · 825 citations

Pathology, Cox-2 Expression, Cancer Biology +16

The landscape of somatic mutations in Down syndrome–related myeloid disorders

Kenichi Yoshida, Tsutomu Toki, Yusuke Okuno et al. · Nature Genetics · 2013 · 381 citations

Down Syndrome, Somatic Variant, Somatic Mutations +7

Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.

Toyoaki Hida, Ken‐ichi Kozaki, Hideki Muramatsu et al. · PubMed · 2000 · 321 citations

Chemoprevention Strategy, Lung Inflammation, Cell Death +17

Somatic SETBP1 mutations in myeloid malignancies

Hideki Makishima, Kenichi Yoshida, Nhu Nguyen et al. · Nature Genetics · 2013 · 264 citations · Full text

Hematological Malignancy, Tumor Biology, Somatic Variant +5

Defective Epstein–Barr virus in chronic active infection and haematological malignancy

Yusuke Okuno, Takayuki Murata, Yoshitaka Sato et al. · Nature Microbiology · 2019 · 231 citations

Lymphoid Neoplasia, Viral Persistence, Immunodeficiencies +7